Rehmann Capital Advisory Group’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$21K Sell
393
-13
-3% -$698 ﹤0.01% 862
2019
Q2
$23.7K Buy
406
+2
+0.5% +$107 ﹤0.01% 1089
2019
Q1
$20K Buy
404
+88
+28% +$3.88K ﹤0.01% 1124
2018
Q4
$11.8K Sell
316
-148
-32% -$5.39K ﹤0.01% 1003
2018
Q3
$17.5K Sell
464
-4
-0.9% -$167 ﹤0.01% 1161
2018
Q2
$20.5K Sell
468
-245
-34% -$11.5K ﹤0.01% 1102
2018
Q1
$36K Buy
+713
New +$42K 0.01% 881

Other funds holding XRAY

Rehmann Capital Advisory Group's XRAY Position: Q3 2019 in Review

Rehmann Capital Advisory Group reduced its Dentsply Sirona (XRAY) stake by 3.2% in Q3 2019, selling an estimated $698 and leaving 393 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #862.

Rehmann Capital Advisory Group first reported a position in XRAY in Q1 2018 and has held it in 7 quarters since. The position peaked at $36K in Q1 2018. 532 funds tracked by Wall St. Rank hold XRAY as of Q3 2019.

  • Rehmann Capital Advisory Group held 393 shares of Dentsply Sirona worth $21K as of Q3 2019.
  • Rehmann Capital Advisory Group sold 13 Dentsply Sirona shares in Q3 2019, an estimated $698.
  • Dentsply Sirona made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #862 holding.
  • Rehmann Capital Advisory Group first reported a position in Dentsply Sirona in Q1 2018 and has held it in 7 quarters since.
  • Rehmann Capital Advisory Group's Dentsply Sirona position peaked at $36K in Q1 2018.
  • 532 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.